Holding ANDA Labeling Review Until Late Cycle Could Minimize Delays From Last-Minute Changes

 
• By Derrick Gingery
  
Clock near deadline
FDA agreed to issue the ANDA labeling assessment closer to the goal date in order to avoid delays from late changes by reference product sponsors • Source: Alamy

More from Generics

More from Products